Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Saved in:
| Title: | Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. |
|---|---|
| Authors: | Li Z; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Xiang T; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Liang B; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Deng H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Wang H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Feng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Quan X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Wang X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Li S; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Lu S; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Yang X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Wang B; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Zelinskyy G; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Trilling M; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Sutter K; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Lu M; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Dittmer U; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Yang D; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Zheng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China., Liu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Dec 22; Vol. 12, pp. 802858. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.802858 |